Results 11 to 20 of about 173,083 (299)

Long-term Outcomes after the Discontinuation of Anti-Tumor Necrosis Factor-α Therapy in Patients with Inflammatory Bowel Disease under Clinical Remission: A Korean Association for the Study of Intestinal Disease Multicenter Study

open access: yesGut and Liver, 2021
Background/Aims: Our study aimed to evaluate the long-term outcomes and risk factors for relapse after anti-tumor necrosis factor (TNF)-α cessation in inflammatory bowel disease (IBD) patients because they are not well established.
Joo Hye Song   +13 more
doaj   +1 more source

Why do we Discontinue Biologic Agents? A Retrospective Study of 11 Years

open access: yesRevista da Sociedade Portuguesa de Dermatologia e Venereologia, 2020
Introduction: Biologic agents acquired a growing relevance in dermatology, however, adverse events (AE) and reasons to discontinue therapy are not completely known.
Francisco Gil   +6 more
doaj   +1 more source

Physicians’ attitudes and experiences about withholding/withdrawing life-sustaining treatments in pediatrics: a systematic review of quantitative evidence

open access: yesBMC Palliative Care, 2023
Background One of the most important and ethically challenging decisions made for children with life-limiting conditions is withholding/withdrawing life-sustaining treatments (LST).
Yajing Zhong   +3 more
doaj   +1 more source

Perfil das condutas médicas que antecedem ao óbito de crianças em um hospital terciário A profile of the medical conduct preceding child death at a tertiary hospital

open access: yesJornal de Pediatria, 2005
OBJETIVO: estudar o perfil de assistência aos pacientes pediátricos que evoluem para o óbito em um hospital universitário, incluindo descrição dos modelos, comparações entre setores, associações de fatores, participações envolvidas e registro das ...
Henrique A.F. Tonelli   +2 more
doaj   +1 more source

The Ethics of Placebo-controlled Trials: Methodological Justifications [PDF]

open access: yes, 2013
The use of placebo controls in clinical trials remains controversial. Ethical analysis and international ethical guidance permit the use of placebo controls in randomized trials when scientifically indicated in four cases: (1) when there is no proven ...
Grady, Christine, Millum, Joseph
core   +1 more source

Reasons withholding intravenous thrombolysis for acute ischemic stroke in an Indonesian Tertiary Center

open access: yesThe Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 2023
Background Intravenous thrombolysis is the current therapy of choice in patients with acute ischemic stroke (AIS). While highly effective, the rate at which the procedure is employed is low.
Rocksy Fransisca V. Situmeang   +5 more
doaj   +1 more source

Withholding and withdrawing life-sustaining therapy in a Moroccan Emergency Department: An observational study

open access: yesBMC Emergency Medicine, 2011
Background Withdrawing and withholding life-support therapy (WH/WD) are undeniably integrated parts of medical activity. However, Emergency Department (ED) might not be the most appropriate place to give end-of life (EOL) care; the legal aspects and ...
Zekraoui Aicha   +9 more
doaj   +1 more source

Physiological Responses of Potato to Short-Term Drought Treatment

open access: yesTurkish Journal of Agriculture: Food Science and Technology, 2016
The study aimed to identify physiological response of potato to drought. For this aim, a drought experiment was carried out by using two different potato varieties, cv.
İlknur Tındaş, Ufuk Demirel
doaj   +1 more source

End of life in the critically ill patient: evaluation of experience of end of life by caregivers (EOLE study)

open access: yesAnnals of Intensive Care, 2021
Background The death rate in intensive care units (ICUs) can reach 20%. More than half occurs after a decision of care withholding/withdrawal. We aimed at describing and evaluating the experience of ICU physicians and nurses involved in the end-of-life ...
The SRLF Trial Group
doaj   +1 more source

Withdrawal from long-term hemodialysis in patients with end-stage renal disease in Taiwan

open access: yesJournal of the Formosan Medical Association, 2013
Withdrawal from dialysis is ethically appropriate for some patients with multiple comorbidities and a shortened life expectancy. Taiwan has the highest prevalence of dialysis patients in the world, and the National Health Insurance (NHI) program offers ...
Chun-Fu Lai   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy